Meeder Asset Management’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-3,988
Closed -$143K 1053
2024
Q4
$143K Buy
+3,988
New +$149K 0.01% 247
2022
Q4
Sell
-13
Closed -$1K 1952
2022
Q3
$1K Sell
13
-1
-7% -$66 ﹤0.01% 2030
2022
Q2
$1K Sell
14
-52
-79% -$3.87K ﹤0.01% 2088
2022
Q1
$5K Buy
+66
New +$5.95K ﹤0.01% 1825
2021
Q4
Sell
-75
Closed -$7K 2295
2021
Q3
$7K Buy
75
+13
+21% +$1.25K ﹤0.01% 1820
2021
Q2
$6K Hold
62
﹤0.01% 1904
2021
Q1
$6K Buy
62
+41
+195% +$3.73K ﹤0.01% 1821
2020
Q4
$2K Sell
21
-31
-60% -$2.4K ﹤0.01% 1537
2020
Q3
$4K Sell
52
-394
-88% -$31.6K ﹤0.01% 1675
2020
Q2
$33K Buy
446
+224
+101% +$17.6K ﹤0.01% 1012
2020
Q1
$13K Sell
222
-343
-61% -$23.9K ﹤0.01% 1418
2019
Q4
$44K Buy
565
+243
+75% +$17.9K ﹤0.01% 1059
2019
Q3
$22K Sell
322
-1,236
-79% -$83K ﹤0.01% 1281
2019
Q2
$123K Buy
1,558
+1,372
+738% +$109K 0.01% 703
2019
Q1
$16K Buy
+186
New +$19.4K ﹤0.01% 1134
2018
Q4
Sell
-365
Closed -$44K 1812
2018
Q3
$44K Sell
365
-4,549
-93% -$565K ﹤0.01% 821
2018
Q2
$567K Buy
4,914
+4,280
+675% +$468K 0.05% 344
2018
Q1
$55K Buy
634
+27
+4% +$2.09K 0.01% 653
2017
Q4
$45K Buy
607
+8
+1% +$535 ﹤0.01% 718
2017
Q3
$35K Sell
599
-330
-36% -$19.5K ﹤0.01% 759
2017
Q2
$60K Buy
929
+833
+868% +$51.3K 0.01% 648
2017
Q1
$6K Buy
+96
New +$5.73K ﹤0.01% 1020
2015
Q4
Sell
-70,022
Closed -$4.69M 864
2015
Q3
$4.69M Buy
+70,022
New +$4.95M 0.46% 54

Other funds holding USNA

Meeder Asset Management's USNA Position: Q1 2025 in Review

Meeder Asset Management sold out of Usana Health Sciences (USNA) in Q1 2025, closing a stake of 3,988 shares — an estimated $143K sold.

Meeder Asset Management first reported a position in USNA in Q3 2015 and held it in 23 quarters. The position peaked at $4.69M in Q3 2015. 162 funds tracked by Wall St. Rank hold USNA as of Q1 2025.

  • Meeder Asset Management reported no remaining Usana Health Sciences position as of Q1 2025 after selling out during the quarter.
  • Meeder Asset Management sold 3,988 Usana Health Sciences shares in Q1 2025, an estimated $143K.
  • Meeder Asset Management first reported a position in Usana Health Sciences in Q3 2015 and held it in 23 quarters.
  • Meeder Asset Management's Usana Health Sciences position peaked at $4.69M in Q3 2015.
  • 162 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2025.

Based on Meeder Asset Management's 13F filing for Q1 2025, filed 7 May 2025.